Chicago Equity Partners LLC cut its stake in Quintiles Transitional Holdings Inc. (NYSE:Q) by 61.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,150 shares of the medical research company’s stock after selling 4,980 shares during the quarter. Chicago Equity Partners LLC’s holdings in Quintiles Transitional Holdings were worth $282,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of Q. ProShare Advisors LLC bought a new position in shares of Quintiles Transitional Holdings in the first quarter valued at about $229,000. Strs Ohio raised its position in shares of Quintiles Transitional Holdings by 2.0% in the first quarter. Strs Ohio now owns 8,594 shares of the medical research company’s stock valued at $692,000 after purchasing an additional 167 shares during the period. Russell Investments Group Ltd. raised its position in shares of Quintiles Transitional Holdings by 15.7% in the first quarter. Russell Investments Group Ltd. now owns 50,658 shares of the medical research company’s stock valued at $4,080,000 after purchasing an additional 6,865 shares during the period. American Century Companies Inc. raised its position in shares of Quintiles Transitional Holdings by 1.1% in the first quarter. American Century Companies Inc. now owns 11,719 shares of the medical research company’s stock valued at $944,000 after purchasing an additional 128 shares during the period. Finally, Suntrust Banks Inc. raised its position in shares of Quintiles Transitional Holdings by 24.9% in the first quarter. Suntrust Banks Inc. now owns 7,101 shares of the medical research company’s stock valued at $570,000 after purchasing an additional 1,414 shares during the period. 91.36% of the stock is currently owned by institutional investors.

Quintiles Transitional Holdings Inc. (Q) opened at 95.43 on Friday. Quintiles Transitional Holdings Inc. has a 12-month low of $70.10 and a 12-month high of $99.95. The firm has a 50-day moving average of $93.47 and a 200 day moving average of $86.36. The company has a market capitalization of $20.66 billion, a price-to-earnings ratio of 276.61 and a beta of 0.63.

Quintiles Transitional Holdings (NYSE:Q) last announced its quarterly earnings results on Thursday, August 3rd. The medical research company reported $1.09 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.05 by $0.04. Quintiles Transitional Holdings had a return on equity of 14.23% and a net margin of 0.82%. The firm had revenue of $1.97 billion for the quarter, compared to analysts’ expectations of $1.96 billion. During the same period in the prior year, the business posted $0.93 earnings per share. The company’s revenue was up 68.7% on a year-over-year basis. Analysts expect that Quintiles Transitional Holdings Inc. will post $4.58 EPS for the current fiscal year.

Quintiles Transitional Holdings announced that its Board of Directors has authorized a stock buyback plan on Wednesday, May 24th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the medical research company to purchase up to 5.4% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s leadership believes its stock is undervalued.

Q has been the topic of several research analyst reports. Zacks Investment Research raised shares of Quintiles Transitional Holdings from a “hold” rating to a “buy” rating and set a $101.00 price objective on the stock in a research report on Thursday, July 27th. BidaskClub raised shares of Quintiles Transitional Holdings from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 19th. Robert W. Baird raised shares of Quintiles Transitional Holdings from an “underperform” rating to a “neutral” rating and raised their price target for the stock from $76.00 to $93.00 in a research report on Friday, July 7th. Credit Suisse Group reaffirmed an “outperform” rating and set a $96.00 price target (up from $94.00) on shares of Quintiles Transitional Holdings in a research report on Tuesday, June 6th. Finally, Stifel Nicolaus reaffirmed a “hold” rating and set a $92.00 price target (up from $87.00) on shares of Quintiles Transitional Holdings in a research report on Friday, August 4th. Eleven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $90.25.

WARNING: “Quintiles Transitional Holdings Inc. (Q) Shares Sold by Chicago Equity Partners LLC” was originally published by Daily Political and is the property of of Daily Political. If you are reading this report on another website, it was stolen and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be accessed at https://www.dailypolitical.com/2017/09/15/quintiles-transitional-holdings-inc-q-shares-sold-by-chicago-equity-partners-llc.html.

In other news, insider Ari Bousbib sold 92,160 shares of the company’s stock in a transaction dated Monday, August 7th. The stock was sold at an average price of $90.35, for a total transaction of $8,326,656.00. Following the sale, the insider now directly owns 1,082,919 shares in the company, valued at $97,841,731.65. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, insider Kevin C. Knightly sold 19,339 shares of the company’s stock in a transaction dated Friday, August 25th. The shares were sold at an average price of $99.51, for a total value of $1,924,423.89. Following the sale, the insider now owns 40,650 shares in the company, valued at $4,045,081.50. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,363,847 shares of company stock worth $618,573,696. Company insiders own 6.40% of the company’s stock.

Quintiles Transitional Holdings Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Institutional Ownership by Quarter for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.